Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tea Kirkegaard Nielsen"'
Autor:
Peter Johannes Holst, Henriette Laursen, Christian Thirion, Lasse Neukirch, Tea Kirkegaard Nielsen, Joana Daradoumis
Publikováno v:
Oncotarget
Endogenous retroviruses (ERVs) that make up 8% of the human genome have been associated with the development and progression of cancer. The murine model system of the melanoma associated retrovirus (MelARV), which is expressed in different murine can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0884a684f37826dcb0ad441ef7a9da
http://europepmc.org/articles/PMC6402721
http://europepmc.org/articles/PMC6402721
Autor:
Lasse Boding, Tea Kirkegaard Nielsen, Terkild B. Buus, Anja T. Fuglsang, Sara Torres-Rusillo, Chella Krishna Vadivel, Maria Gluud, Niels Ødum, Andreas Willerslev-Olsen, Carsten Geisler, Jenny L. Persson, Thorbjørn Krejsgaard, Charlotte M. Bonefeld, Anders Woetmann
Publikováno v:
Vadivel, C K, Gluud, M, Torres-rusillo, S, Boding, L, Willerslev-olsen, A, Buus, T B, Nielsen, T K, Persson, J L, Bonefeld, C M, Geisler, C, Krejsgaard, T, Fuglsang, A T, Odum, N & Woetmann, A 2021, ' JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL) ', Cancers, vol. 13, no. 2, 280 . https://doi.org/10.3390/cancers13020280
Cancers, Vol 13, Iss 280, p 280 (2021)
Cancers
Volume 13
Issue 2
Cancers, Vol 13, Iss 280, p 280 (2021)
Cancers
Volume 13
Issue 2
Perturbation in JAK-STAT signaling has been reported in the pathogenesis of cutaneous T cell lymphoma (CTCL). JAK3 is predominantly associated with the intra-cytoplasmic part of IL-2R&gamma
c located in the plasma membrane of hematopoietic cells
c located in the plasma membrane of hematopoietic cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d11028c51bace6176fb19a3328a50d
https://curis.ku.dk/ws/files/255503670/cancers_13_00280.pdf
https://curis.ku.dk/ws/files/255503670/cancers_13_00280.pdf
Autor:
I.A. Baldueva, Tea Kirkegaard Nielsen, Stig Larsen, Elena I. Fedoros, Alexander M. Scherbakov, Andrey V. Panchenko, Evgeny Yu Drobyshev, Vladimir N. Anisimov, Anastasia V Malek, Stig Lofberg, Alexey M. Belyaev, V.N. Bykov, Irina V. Perminova
Publikováno v:
OncoTarget
Oncotarget
Anisimov, V N, Larsen, S, Lofberg, S, Baldueva, I A, Malek, A V, Nielsen, T K, Fedoros, E I, Perminova, I V, Drobyshev, E Y, Bykov, V N, Panchenko, A V, Scherbakov, A M & Belyaev, A M 2017, ' Results and prospects of development of new polyphenolic drugs for cancer patients ', OncoTarget, vol. 8, no. 59, pp. 100951-100956 . https://doi.org/10.18632/oncotarget.22307
Oncotarget
Anisimov, V N, Larsen, S, Lofberg, S, Baldueva, I A, Malek, A V, Nielsen, T K, Fedoros, E I, Perminova, I V, Drobyshev, E Y, Bykov, V N, Panchenko, A V, Scherbakov, A M & Belyaev, A M 2017, ' Results and prospects of development of new polyphenolic drugs for cancer patients ', OncoTarget, vol. 8, no. 59, pp. 100951-100956 . https://doi.org/10.18632/oncotarget.22307
The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53fab85338622799f7d1f72365a8683c
https://doi.org/10.18632/oncotarget.22307
https://doi.org/10.18632/oncotarget.22307